A citation-based method for searching scientific literature

Nicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, David M Hansell, Susan J Copley, Toby M Maher, Tamera J Corte, Clare R Sander, Jonathan Ratoff, Anand Devaraj, Gracijela Bozovic, Christopher P Denton, Carol M Black, Roland M du Bois, Athol U Wells. Am J Respir Crit Care Med 2008
Times Cited: 570







List of co-cited articles
775 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
368
42

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Donald P Tashkin, Michael D Roth, Philip J Clements, Daniel E Furst, Dinesh Khanna, Eric C Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R Volkmann, Suzanne Kafaja,[...]. Lancet Respir Med 2016
373
30

Changes in causes of death in systemic sclerosis, 1972-2002.
Virginia D Steen, Thomas A Medsger. Ann Rheum Dis 2007
915
29

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Arthritis Rheum 2013
29

Cyclophosphamide versus placebo in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Jonathan Goldin, Michael D Roth, Daniel E Furst, Edgar Arriola, Richard Silver, Charlie Strange, Marcy Bolster,[...]. N Engl J Med 2006
908
28

Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.
Nicole S Goh, Rachel K Hoyles, Christopher P Denton, David M Hansell, Elisabetta A Renzoni, Toby M Maher, Andrew G Nicholson, Athol U Wells. Arthritis Rheumatol 2017
121
27

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
22

Systemic sclerosis.
Christopher P Denton, Dinesh Khanna. Lancet 2017
546
21

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
Anthony J Tyndall, Bettina Bannert, Madelon Vonk, Paolo Airò, Franco Cozzi, Patricia E Carreira, Dominique Farge Bancel, Yannick Allanore, Ulf Müller-Ladner, Oliver Distler,[...]. Ann Rheum Dis 2010
606
21

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Kevin R Flaherty, Athol U Wells, Vincent Cottin, Anand Devaraj, Simon L F Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser,[...]. N Engl J Med 2019
383
20

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Rachel K Hoyles, Ross W Ellis, Jessica Wellsbury, Belinda Lees, Pauline Newlands, Nicole S L Goh, Christopher Roberts, Sujal Desai, Ariane L Herrick, Neil J McHugh,[...]. Arthritis Rheum 2006
406
19

Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.
Elizabeth R Volkmann, Donald P Tashkin, Myung Sim, Ning Li, Ellen Goldmuntz, Lynette Keyes-Elstein, Ashley Pinckney, Daniel E Furst, Philip J Clements, Dinesh Khanna,[...]. Ann Rheum Dis 2019
60
31

Update of EULAR recommendations for the treatment of systemic sclerosis.
Otylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, Mike Becker, Agnieszka Kulak, Yannick Allanore, Oliver Distler, Philip Clements, Maurizio Cutolo, Laszlo Czirjak,[...]. Ann Rheum Dis 2017
358
18

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Aryeh Fischer, Katerina M Antoniou, Kevin K Brown, Jacques Cadranel, Tamera J Corte, Roland M du Bois, Joyce S Lee, Kevin O Leslie, David A Lynch, Eric L Matteson,[...]. Eur Respir J 2015
422
17

Mapping and predicting mortality from systemic sclerosis.
Muriel Elhai, Christophe Meune, Marouane Boubaya, Jérôme Avouac, Eric Hachulla, Alexandra Balbir-Gurman, Gabriela Riemekasten, Paolo Airò, Beatriz Joven, Serena Vettori,[...]. Ann Rheum Dis 2017
177
17

Prediction of pulmonary complications and long-term survival in systemic sclerosis.
Svetlana I Nihtyanova, Benjamin E Schreiber, Voon H Ong, Daniel Rosenberg, Pia Moinzadeh, J Gerrard Coghlan, Athol U Wells, Christopher P Denton. Arthritis Rheumatol 2014
196
17

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.
Demosthenes Bouros, Athol U Wells, Andrew G Nicholson, Thomas V Colby, Vlasis Polychronopoulos, Panos Pantelidis, Patricia L Haslam, Dimitris A Vassilakis, Carol M Black, Roland M du Bois. Am J Respir Crit Care Med 2002
460
15

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease.
E J Kim, B M Elicker, F Maldonado, W R Webb, J H Ryu, J H Van Uden, J S Lee, T E King, H R Collard. Eur Respir J 2010
278
15

Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group.
Dinesh Khanna, Shikha Mittoo, Rohit Aggarwal, Susanna M Proudman, Nicola Dalbeth, Eric L Matteson, Kevin Brown, Kevin Flaherty, Athol U Wells, James R Seibold,[...]. J Rheumatol 2015
70
20

Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review.
Tiffany A Winstone, Deborah Assayag, Pearce G Wilcox, James V Dunne, Cameron J Hague, Jonathon Leipsic, Harold R Collard, Christopher J Ryerson. Chest 2014
115
14

Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort.
Anna-Maria Hoffmann-Vold, Håvard Fretheim, Anne-Kristine Halse, Marit Seip, Helle Bitter, Marianne Wallenius, Torhild Garen, Anne Salberg, Cathrine Brunborg, Øyvind Midtvedt,[...]. Am J Respir Crit Care Med 2019
48
29

Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
Yossra A Suliman, Rucsandra Dobrota, Dörte Huscher, Thi D L Nguyen-Kim, Britta Maurer, Suzana Jordan, Rudolf Speich, Thomas Frauenfelder, Oliver Distler. Arthritis Rheumatol 2015
83
16

Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model.
Wanlong Wu, Suzana Jordan, Mike Oliver Becker, Rucsandra Dobrota, Britta Maurer, Håvard Fretheim, Shuang Ye, Elise Siegert, Yannick Allanore, Anna-Maria Hoffmann-Vold,[...]. Ann Rheum Dis 2018
46
28

Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
Richard K Burt, Sanjiv J Shah, Karin Dill, Thomas Grant, Mihai Gheorghiade, James Schroeder, Robert Craig, Ikuo Hirano, Karin Marshall, Eric Ruderman,[...]. Lancet 2011
272
13

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
Dinesh Khanna, Christopher P Denton, Angelika Jahreis, Jacob M van Laar, Tracy M Frech, Marina E Anderson, Murray Baron, Lorinda Chung, Gerhard Fierlbeck, Santhanam Lakshminarayanan,[...]. Lancet 2016
281
13


Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
13

Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
Clive A Kelly, Vadivelu Saravanan, Mohamed Nisar, Subha Arthanari, Felix A Woodhead, Alec N Price-Forbes, Julie Dawson, Navtej Sathi, Yasmeen Ahmad, Gouri Koduri,[...]. Rheumatology (Oxford) 2014
222
13

Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease.
Joshua J Solomon, Jonathan H Chung, Gregory P Cosgrove, M Kristen Demoruelle, Evans R Fernandez-Perez, Aryeh Fischer, Stephen K Frankel, Stephen B Hobbs, Tristan J Huie, Jill Ketzer,[...]. Eur Respir J 2016
133
13

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
13

Standardisation of spirometry.
M R Miller, J Hankinson, V Brusasco, F Burgos, R Casaburi, A Coates, R Crapo, P Enright, C P M van der Grinten, P Gustafsson,[...]. Eur Respir J 2005
12

Severe restrictive lung disease in systemic sclerosis.
V D Steen, C Conte, G R Owens, T A Medsger. Arthritis Rheum 1994
354
12

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
U A Walker, A Tyndall, L Czirják, C Denton, D Farge-Bancel, O Kowal-Bielecka, U Müller-Ladner, C Bocelli-Tyndall, M Matucci-Cerinic. Ann Rheum Dis 2007
520
12

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.
Owen A Moore, Nicole Goh, Tamera Corte, Hannah Rouse, Oliver Hennessy, Vivek Thakkar, Jillian Byron, Joanne Sahhar, Janet Roddy, Eli Gabbay,[...]. Rheumatology (Oxford) 2013
104
12

Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.
Anna-Maria Hoffmann-Vold, Trond M Aaløkken, May Brit Lund, Torhild Garen, Øyvind Midtvedt, Cathrine Brunborg, Jan Tore Gran, Øyvind Molberg. Arthritis Rheumatol 2015
72
16

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Keith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, Peter A McSweeney, Ashley Pinckney, Beverly Welch, Maureen D Mayes, Richard A Nash, Leslie J Crofford, Barry Eggleston,[...]. N Engl J Med 2018
192
12

An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial.
Dinesh Khanna, Carlo Albera, Aryeh Fischer, Nader Khalidi, Ganesh Raghu, Lorinda Chung, Dan Chen, Elena Schiopu, Margit Tagliaferri, James R Seibold,[...]. J Rheumatol 2016
121
12

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
Jacob M van Laar, Dominique Farge, Jacob K Sont, Kamran Naraghi, Zora Marjanovic, Jérôme Larghero, Annemie J Schuerwegh, Erik W A Marijt, Madelon C Vonk, Anton V Schattenberg,[...]. JAMA 2014
339
12

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Ann Rheum Dis 2013
871
11

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.
Veronika K Jaeger, Elina G Wirz, Yannick Allanore, Philipp Rossbach, Gabriela Riemekasten, Eric Hachulla, Oliver Distler, Paolo Airò, Patricia E Carreira, Alexandra Balbir Gurman,[...]. PLoS One 2016
78
14

Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.
Dinesh Khanna, Vivek Nagaraja, Chi-Hong Tseng, Fereidoun Abtin, Robert Suh, Grace Kim, Athol Wells, Daniel E Furst, Philip J Clements, Michael D Roth,[...]. Arthritis Res Ther 2015
49
22

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
10

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Michael D Roth, Daniel E Furst, Richard M Silver, Jonathan Goldin, Edgar Arriola, Charlie Strange, Marcy B Bolster,[...]. Am J Respir Crit Care Med 2007
262
10

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Dinesh Khanna, Celia J F Lin, Daniel E Furst, Jonathan Goldin, Grace Kim, Masataka Kuwana, Yannick Allanore, Marco Matucci-Cerinic, Oliver Distler, Yoshihito Shima,[...]. Lancet Respir Med 2020
56
17

Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis.
Russell Steele, Marie Hudson, Ernest Lo, Murray Baron. Arthritis Care Res (Hoboken) 2012
67
13

Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).
Dinesh Khanna, Christopher P Denton, Celia J F Lin, Jacob M van Laar, Tracy M Frech, Marina E Anderson, Murray Baron, Lorinda Chung, Gerhard Fierlbeck, Santhanam Lakshminarayanan,[...]. Ann Rheum Dis 2018
122
9

Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?
Erica L Herzog, Aditi Mathur, Andrew M Tager, Carol Feghali-Bostwick, Frank Schneider, John Varga. Arthritis Rheumatol 2014
103
9

Treatment Algorithms for Systemic Sclerosis According to Experts.
Andreu Fernández-Codina, Kyle M Walker, Janet E Pope. Arthritis Rheumatol 2018
74
12

Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Jorge A Zamora-Legoff, Megan L Krause, Cynthia S Crowson, Jay H Ryu, Eric L Matteson. Arthritis Rheumatol 2017
56
16

Management of systemic sclerosis-associated interstitial lung disease.
David Roofeh, Sara Jaafar, Dharshan Vummidi, Dinesh Khanna. Curr Opin Rheumatol 2019
29
31


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.